Department of Pediatrics, Contra Costa Regional Medical Center and Health Centers, Martinez, California; and Department of Family and Community Medicine, University of California, Davis, California
| ABSTRACT |
|---|
|
|
|---|
Objective. To determine if the presence of anemia correctly diagnoses iron deficiency (ID) and if the absence of anemia correctly rules out ID in young children.
Methodology. An analysis of data from the US National Health and Nutrition Examination Survey III (19881994) was performed. Subjects were children 12 to 35 months old for whom complete blood counts and cardinal measures of iron nutrition (ferritin, transferrin saturation, and free erythrocyte protoporphyrin) were reported.
Results. In the US National Health and Nutrition Examination Survey III, the prevalence of ID ranged from 6% to 18% in various subpopulations of toddlers. In the general population, the positive predictive value of Hb concentration ([Hb]) <110 g/L for ID was 29% (95% confidence interval [CI]: 2038%), and the sensitivity was 30% (95% CI: 2040%). Changing the diagnostic cutoff point to [Hb] <107 g/L resulted in a positive predictive value of 38% (95% CI: 2452%) but lowered the sensitivity to 15% (95% CI: 722%).
Conclusions. ID remains common in the United States. In agreement with other reports, anemia in toddlers in developed countries is more likely to be due to causes other than ID. Conversely, most children with ID are not anemic. Many false-positive and false-negative results render the measurement of Hb a screening test of relatively little value. The current detection strategy needlessly treats and retests many children without ID and leaves many iron-deficient toddlers unattended.
Key Words: African Americans anemia child preschool evidence-based medicine hemoglobin Mexican Americans iron deficiency iron-deficiency anemia NHANES III positive predictive value poverty sensitivity toddlers United States
Abbreviations: Hb, hemoglobin ID, iron deficiency WIC, Supplemental Nutrition Program for Women, Infants, and Children NHANES, National Health and Nutrition Examination Survey IDA iron-deficiency anemia PPV, positive predictive value BRR, balanced repeated replication EPP, erythrocyte protoporphyrin MCV, mean corpuscular volume CI, confidence interval
Many of the 8 million American children between 1 and 3 years old routinely have their hemoglobin (Hb) measured. Economically disadvantaged children are more likely to be screened for iron deficiency (ID) by this method. Many Medicaid programs require universal screening, and the Supplemental Nutrition Program for Women, Infants, and Children (WIC) program requires a Hb determination for children to enroll. Although children in this age group are the most likely to be iron-deficient1,2 and are least likely to meet their recommended intakes for iron,3,4 there is scant evidence to support this current practice. The National Health and Nutrition Examination Survey (NHANES) II (19761980) showed that the likelihood of an anemic child 1 to 5 years old being iron-deficient was <50%.5 The utility of this test has not been considered in 20 years.
The prevalence of ID and iron-deficiency anemia (IDA) in NHANES III was reported previously.1 That study did not report the prevalence of anemia of all causes, permitting the calculation of the positive predictive value (PPV) of anemia for ID. Was the PPV different from NHANES II? The previous study did not apply demographic stratification. Is the sensitivity of screening with the Hb test higher in children living below the poverty line? How does the usefulness of the test compare in children from different ethnic groups?
This is the first consideration of the prevalence of ID, IDA, and anemia of all causes in young children living in different economic strata and different ethnic groups. The resulting statistics are intended for practitioners.
| MATERIALS AND METHODS |
|---|
|
|
|---|
2 months old. The NHANESs are performed continuously across the United States in specially designed medical examination centers. They are excellent sources of data of very high quality. A CD-ROM of public-use data files from NHANES III was obtained from the National Technical Information Service (www.ntis.gov/fcpc). The Statistical Program for the Social Sciences (SPSS) version 11.06 and Wesvar 4.27 were used to analyze the data.
The US NHANES8 is a multistage, stratified population survey (rather than a random sample), which is a common sampling design. Populations of particular interest are oversampled to assure their representation. For example, black children comprised 29% of children tested in NHANES III, although they represented 17% of the population in this age range in 1988-1994. Children living below the poverty line comprised 40% of the children surveyed but represented 27% of the toddlers in the United States in those years. The methodology of NHANES acknowledges these biases and assigns sampling weights, numerical factors that are inversely proportional to the likelihood of a subject being selected. Other weights are assigned to correct for nonresponse and adjustments in estimates of the census.
A full sample weight and 52 partial sampling weights are calculated for each study subject. Balanced repeated replication (BRR)9 is a statistical method recommended to calculate estimates for the NHANES.8 The Fay method, with K = 0.3, was used.
Subjects were 12 to 35 months (inclusive) old at the time of examination. The poverty index ratio was used to stratify the subjects according to their families' incomes. NHANES assigned the poverty index ratio based on a family's self-reported income and size, using tables published each year by the Bureau of the Census. The race/ethnicity classification of the subjects was based on self-report.
All subjects had complete blood counts and cardinal measures of iron nutrition (ferritin, transferrin saturation, and free erythrocyte protoporphyrin [EPP]). Concentrations of lead in serum were also considered when available. According to the documentation accompanying the NHANES, blood was collected by venipuncture and samples were processed at the Division of Environmental Health Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention. Analyses were performed according to detailed plans.10
In this study, ID was diagnosed if
2 of the following pertained: ferritin <10 µg/L, transferrin saturation <10%, and EPP >1.42 µmol/L red blood cells. Anemia was diagnosed if Hb concentration ([Hb]) was <110 g/L. IDA was diagnosed if anemia accompanied ID. The National Center for Health Statistics of the US Centers for Disease Control and Prevention1,2 and other authorities11 use this criterion standard; it was developed by the Expert Scientific Working Group.12
| RESULTS |
|---|
|
|
|---|
|
|
Figure 1 depicts the relative distributions of the 1289 subjects from NHANES III who had complete values for [Hb], [ferritin], % transferrin saturation, and [EPP]. Of these subjects, 140 could be classified as ID (Fig 1, bottom half), 48 had IDA (Fig 1, lower-left quadrant), and 106 had anemia without ID (Fig 1, upper-left quadrant). The histogram compares the distributions before the consideration of sampling weights and qualitatively displays the overlap of iron-sufficient and iron-deficient populations.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
This Gaussian definition of abnormality does not permit the calculation of the diagnostic probability that a patient has ID. That essential measure is the PPV, where PPV = true-positives/(true-positives + false-positives). One needs to know the prevalence of anemia of all causes (the denominator of this equation). Surprisingly, the prevalence of anemia of all causes was omitted in most previous reports about NHANES.1,2 An exception was a report13 of 9.6% prevalence for anemia of all causes in children 1 to 5 years old from the general population sampled in NHANES III. This finding compares closely with the 9% (712%) presented in the first row, third column of Table 2.
The results of the present study indicate that Hb is not a clinically useful test for assessment of iron adequacy among toddlers in the United States. The PPV reflects how accurately [Hb] diagnoses ID. Among the general population, an anemic toddler has 1 chance in 3 of being iron-deficient. The sensitivity of this test is of similar magnitude: a [Hb] of <110 g/L is only seen in ID one third of the time. Lowering the [Hb] used as a cutoff does increase the PPV slightly but at the cost of a lower test sensitivity. At best, the Hb test is a screening procedure of relatively little value.
Dividing the subjects into subsets does not reveal any striking difference in the utility of the test for any economic or ethnic group. The overall trend was PPV and sensitivities of
30%. Some of the estimates are possibly unreliable, because smaller sample sizes (n < 30) may not allow normal approximations. For example, among Mexican American children depicted in Table 2 (indicated by
), 23 had IDA and 47 had anemia of all types. The resulting estimate of the PPV after BRR was 53% (35-72%), an estimate with a wide, unsatisfactory CI. Even large and well-conducted surveys such as NHANES III cannot provide enough statistical power to assess the utility of the Hb test with precision.
The methodology of NHANES specified collection of venous blood and analysis by carefully calibrated Coulter counters.10 In clinical practice, capillary blood is often collected and analyzed with bench-top hemoglobinometers or by centrifuging microhematocrit tubes. Specimens obtained by these methods cannot be compared with those reported here.
The cause of the majority of anemia among the children with adequate stores of iron in NHANES III cannot be explained completely from the available data. Serum folate, B12, Hb electrophoresis, and reticulocyte counts were not performed in subjects in the 12- to 35-month-old age group.
and ß thalassemia traits, hemoglobinopathies (such as S, C, and E traits), cytostructural abnormalities, and enzyme defects (glucose-6-phosphate dehydrogenase deficiency) are hypothetical contributors. Exact estimates of these conditions in the US population are not available. Anemia associated with acute and chronic infections14 possibly explains many cases.
Other Populations
Limited recent data from NHANES were available at the time of writing (July 2004). The NHANES 19992000 data release contains complete hematologic and nutritional observations of only 319 young children, and the NHANES 20012002 release contains none. According to the release schedule for NHANES,15 we will have to wait until at least 2006 to extend these studies among toddlers in the US.
Soh et al16 performed a community-based cross-sectional survey of randomly selected, 6- to 24-month-old children in New Zealand. Their criterion for ID was the ferritin, EPP, and MCV model. Children with a C-reactive protein level of >10 mg/L (who might have suffered recent infections) were excluded from consideration. Among 169 toddlers 12 to 24 months old, 22% had [Hb] of <110 g/L, 2.5% had IDA, and 5.0% had ID without anemia. In that study, the PPV of [Hb] for ID can be calculated as 2.5%/22% = 11% (95% CI: 913%) and the sensitivity can be calculated as 2.5%/7.5% = 33% (95% CI: 2640%).
A study of 488 infants from 11 European countries17 also indicated poor utility of the Hb test. Hb, serum ferritin, MCV, transferrin saturation, and serum transferrin receptor concentrations were measured at 12 months. The prevalence of ID was 7.2%, of ID anemia 2.3%, and of anemia of all causes 9.4%. More than 40% of anemia was associated with normal iron status (all indicators of iron nutrition normal) and associated with an increased frequency of recent infections. Another 35% of anemic patients had only 1 abnormal iron indicator. Thus, at 1 year of age, the PPV of anemia for ID was 2.3%/9.4% = 24% (95% CI: 2028%) and the sensitivity was 2.3%/7.2% = 32% (95% CI: 2836%).
The National Diet and Nutrition Survey18 took place in Mainland Britain in 19921993. It was a cross-sectional study considered to be representative of preschool children in the general population. Serum EPP was not measured in this study, so it is not possible to calculate the percentage of children who were iron-deficient by the Centers for Disease Control and Prevention definition. Blood was obtained from 1003 subjects 1.5 to 4.5 years old. Eight percent of the children had a [Hb] of <110 g/L, but only 3.4% had a low Hb with a ferritin level of <10 µg/L. Thus, the PPV of anemia for iron depletion was 3.4%/8% = 42%. Because ID is a less common condition than iron depletion (low [ferritin]), the PPV of anemia for ID in British children in that survey can be estimated at <42%.
Kazal19 found that the hematocrit failed to detect iron depletion (low [ferritin]) in infants and toddlers in the United States. Hematocrit and ferritin concentrations were measured from capillary blood from 321 children 9 to 18 months old. All were from low-income households. Children with acute illnesses and those receiving medicinal iron were excluded from the study. Six (1.9%) of the children were anemic, but none had low [ferritin]. Fifty-one infants (15.9%) had [ferritin] <10 µg/dL, but none were anemic.
Implications
ID is as important a problem as it ever was, but 2 aspects must be recognized. First, most anemic toddlers in the United States do not have ID. Second, the majority of toddlers with ID in the United States are not anemic. Screening children in this age group for anemia misdirects our attention from these findings. Assuming that [Hb] is an accurate proxy for iron status is misleading. It gives us false assurance that children without anemia are iron-sufficient, although they may be at significant risk. No candidate test for ID (transferrin receptors,20 reticulocyte Hb concentration,21 or free erythrocyte protoporphyrin alone13) is likely to allow screening for ID in a more selective fashion than [Hb].
Iron is present in 200 to 300 enzymes and is important for health. We work to prevent ID because ID severe enough to cause IDA is associated with developmental disabilities.22,23 It is unclear if these problems are reversible if iron stores are repleted.2427 Because the threshold effects of ID on development have not been established, it is prudent to assure that there are adequate stores during periods of growth and development. How can we assure good nutrition when, currently, secondary prevention is unlikely to be successful?
Much of the decline in the prevalence of IDA in recent years has been a result of primary preventative strategies, especially the fortification of formula and cereals with iron. One author has argued that daily supplementation should be continued through the second year of life.28 Numerous studies worldwide have demonstrated the effectiveness of weekly preventative supplementation.2932 Given that most ID is not associated with anemia, these seem the most practical directions for future efforts. Screening toddlers for ID by Hb testing is inefficient. Prophylactic supplementation is likely to be more effective than attempting to identify and treat US children who are iron-deficient.
| ACKNOWLEDGMENTS |
|---|
I thank Mitch Watnick, PhD (Senior Statistician, Statistics Laboratory, University of California, Davis, CA), for statistical consultation. Leora Benioff, PhD, Guenter Hofstadler, MD, MPH, and John Lee, MD, provided reviews of this study; Sally Bly provided secretarial assistance; and Sally Chu (Degnan Medical Library, Contra Costa Regional Medical Center, Martinez, CA) provided reference materials.
| FOOTNOTES |
|---|
Address correspondence to Keith C. White, MD, Contra Costa Regional Medical Center, 2500 Alhambra Ave, Martinez, CA 94553. E-mail: kcwhite{at}ucdavis.edu
No conflict of interest declared.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. M. Brotanek, J. Gosz, M. Weitzman, and G. Flores Secular Trends in the Prevalence of Iron Deficiency Among US Toddlers, 1976-2002 Arch Pediatr Adolesc Med, April 1, 2008; 162(4): 374 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Finkelstein, M. S Wahl, Y. Bentur, T. Schechter, B. Z. Garty, T. B Erickson, G. Chodick, A. Cahana, B. J Mounstephen, G. Koren, et al. Universal versus Selective Iron Supplementation for Infants and the Risk of Unintentional Poisoning in Young Children: A Comparative Study of Two Populations Ann. Pharmacother., March 1, 2007; 41(3): 414 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Hicks, N. Zavaleta, Z. Chen, S. A. Abrams, and B. Lonnerdal Iron Deficiency, but Not Anemia, Upregulates Iron Absorption in Breast-Fed Peruvian Infants J. Nutr., September 1, 2006; 136(9): 2435 - 2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Crowell, A. M. Ferris, R. J. Wood, P. Joyce, and H. Slivka Comparative Effectiveness of Zinc Protoporphyrin and Hemoglobin Concentrations in Identifying Iron Deficiency in a Group of Low-Income, Preschool-Aged Children: Practical Implications of Recent Illness Pediatrics, July 1, 2006; 118(1): 224 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Baggett, A. J. Parkinson, P. T. Muth, B. D. Gold, and B. D. Gessner Endemic Iron Deficiency Associated With Helicobacter pylori Infection Among School-Aged Children in Alaska Pediatrics, March 1, 2006; 117(3): e396 - e404. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Siddiq, I. A. Ayoub, J. C. Chavez, L. Aminova, S. Shah, J. C. LaManna, S. M. Patton, J. R. Connor, R. A. Cherny, I. Volitakis, et al. Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition: A TARGET FOR NEUROPROTECTION IN THE CENTRAL NERVOUS SYSTEM J. Biol. Chem., December 16, 2005; 280(50): 41732 - 41743. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Schneider, M. L Fujii, C. L Lamp, B. Lonnerdal, K. G Dewey, and S. Zidenberg-Cherr Anemia, iron deficiency, and iron deficiency anemia in 12-36-mo-old children from low-income families Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1269 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Brotanek, J. S. Halterman, P. Auinger, G. Flores, and M. Weitzman Iron Deficiency, Prolonged Bottle-Feeding, and Racial/Ethnic Disparities in Young Children Arch Pediatr Adolesc Med, November 1, 2005; 159(11): 1038 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. White Anemia Is an Important Finding and Is Likely to Respond to Iron Therapy: In Reply Pediatrics, November 1, 2005; 116(5): 1259 - 1259. [Full Text] [PDF] |
||||
![]() |
C. M. Wright, G. P. Summerfield, and R. Moy Anemia Is an Important Finding and Is Likely to Respond to Iron Therapy Pediatrics, November 1, 2005; 116(5): 1258 - 1259. [Full Text] [PDF] |
||||
![]() |
Anaemia doesn't predict iron deficiency among toddlers BMJ, July 2, 2005; 331(7507): . [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||